» Articles » PMID: 19372239

Promotion of Human Trophoblasts Invasion by Gonadotropin-releasing Hormone (GnRH) I and GnRH II Via Distinct Signaling Pathways

Overview
Journal Mol Endocrinol
Date 2009 Apr 18
PMID 19372239
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The potential roles of GnRH I and GnRH II have been assigned in promoting the invasive capacity of human trophoblasts by regulating matrix metalloproteinases-2 and -9, type I tissue inhibitor of matrix metalloproteinase, and urokinase plasminogen activator/plasminogen activator inhibitor protease systems during human placentation, and GnRH II has been shown to be more potent than GnRH I. However, the mechanisms for the differential effects of these two hormones remain unclear. In this study, we examined the invasion-promoting effects and the signaling pathways of GnRH I and GnRH II in human trophoblasts. The data revealed that both GnRH I and GnRH II were key autocrine and/or paracrine regulators in facilitating trophoblast invasion. The GnRH receptor antagonist (Antide) and specific small interfering RNA for GnRH receptor inhibited the regulatory effects of GnRH I, but not GnRH II, on trophoblast invasion. Both GnRH I and II activated protein kinase C, ERK1/2, and c-Jun N-terminal kinase to mediate their effects on trophoblast invasion, whereas only GnRH II elicited invasion-promoting action through transactivating the tyrosine kinase activity of epidermal growth factor receptor in trophoblasts. Our observations elucidate a ligand-dependent selective cross-communication between GnRH receptor and epidermal growth factor receptor signaling systems in human trophoblastic cell, and this would further our understanding on the differentially biological significance of these two forms of GnRH in extrapituitary tissues.

Citing Articles

Role of gonadotropin-releasing hormone 2 and its receptor in human reproductive cancers.

Desaulniers A, White B Front Endocrinol (Lausanne). 2024; 14:1341162.

PMID: 38260130 PMC: 10800933. DOI: 10.3389/fendo.2023.1341162.


In Vitro Fertilization Outcomes With a Dual Trigger in Normoresponders in Antagonist Cycles.

Cevher Akdulum M, Arik S, Demirdag E, Erdem M, Erdem A Cureus. 2023; 15(9):e45623.

PMID: 37868584 PMC: 10588958. DOI: 10.7759/cureus.45623.


HAND1 knockdown disrupts trophoblast global gene expression.

Fresch R, Courtney J, Brockway H, Wilson R, Jones H Physiol Rep. 2023; 11(2):e15553.

PMID: 36695714 PMC: 9875743. DOI: 10.14814/phy2.15553.


Conditional loss of ERK1 and ERK2 results in abnormal placentation and delayed parturition in the mouse.

Brown J, Sones J, Angulo C, Abbott K, Miller A, Boehm U Sci Rep. 2019; 9(1):9641.

PMID: 31270345 PMC: 6610138. DOI: 10.1038/s41598-019-45997-0.


Physiological profile of undifferentiated bovine blastocyst-derived trophoblasts.

Pillai V, Siqueira L, Das M, Kei T, Tu L, Herren A Biol Open. 2019; 8(5).

PMID: 30952696 PMC: 6550082. DOI: 10.1242/bio.037937.


References
1.
Islami D, Bischof P, Chardonnens D . Possible interactions between leptin, gonadotrophin-releasing hormone (GnRH-I and II) and human chorionic gonadotrophin (hCG). Eur J Obstet Gynecol Reprod Biol. 2003; 110(2):169-75. DOI: 10.1016/s0301-2115(03)00185-4. View

2.
Grosse R, Roelle S, HERRLICH A, Hohn J, Gudermann T . Epidermal growth factor receptor tyrosine kinase mediates Ras activation by gonadotropin-releasing hormone. J Biol Chem. 2000; 275(16):12251-60. DOI: 10.1074/jbc.275.16.12251. View

3.
Kim H, Mui K, Nikrodhanond A, Tamayo N . Regulation of gonadotropin-releasing hormone in nonhypothalamic tissues. Semin Reprod Med. 2007; 25(5):326-36. DOI: 10.1055/s-2007-984738. View

4.
Lamarca H, Dash P, Vishnuthevan K, Harvey E, Sullivan D, Morris C . Epidermal growth factor-stimulated extravillous cytotrophoblast motility is mediated by the activation of PI3-K, Akt and both p38 and p42/44 mitogen-activated protein kinases. Hum Reprod. 2008; 23(8):1733-41. PMC: 2733823. DOI: 10.1093/humrep/den178. View

5.
Qiu Q, Yang M, Tsang B, Gruslin A . EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves activation of both PI3K and MAPK signalling pathways. Reproduction. 2004; 128(3):355-63. DOI: 10.1530/rep.1.00234. View